Buprenorphine 60687-0492-21
- Manufacturer
- American Health Packaging
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- February 6, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA207276
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 8 mg/1 |
Drug Class
Partial Opioid Agonist [EPC]Partial Opioid Agonists [MoA]
Selected Package
60687-0492-21Selected30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-492-21) / 1 TABLET in 1 BLISTER PACK (60687-492-11)